Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals
Go back to Theravance Biopharma Announces Sale of VIBATIV® (telavancin) to Cumberland Pharmaceuticals| Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) | Delayed: 5.83 +0.26 (4.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.57 | 52 Week High | $5.95 | |||
| Open | $5.59 | 52 Week Low | $4.20 | |||
| Day High | $5.95 | P/E | 97.17 | |||
| Day Low | $5.50 | EPS | $0.06 | |||
| Volume | 51,660 | |||||
| (NASDAQ: TBPH) | Delayed: 16.97 +0.41 (2.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.56 | 52 Week High | $38.92 | |||
| Open | $16.70 | 52 Week Low | $12.87 | |||
| Day High | $17.10 | P/E | N/A | |||
| Day Low | $16.64 | EPS | $0.00 | |||
| Volume | 676,267 | |||||
